Cancer52 – Impact of COVID-19 on people with rare and less common cancers in England

By Leanne Talbot

Posted 6 years ago

27/08/2020 1pm

About the survey

Cancer52 ran an online survey of people with rare and less common cancers during June 2020. Respondents were recruited via member charities’ networks and communications. Since respondents were found via Cancer52’s member charities, respondents to the survey are more likely to  be using the support of charities and more likely to have been diagnosed  some time before the pandemic began.

Click here to read the results of the 2020 patient survey.

www.cancer52.org.uk

Catch up on the latest news, stories and updates

Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. ...